相关实验视频

Updated: Jul 10, 2025

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

新辅助化疗对妇科瘤免疫微环境的影响

Jing Xue^1,2, Xia Yan^1,3, Qin Ding^1,3

¹Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, PR China.

Annals of medicine

|November 20, 2023

概括

新辅助化疗 (NACT) 在妇科癌症中改变瘤免疫微环境 (TIME),具有组合疗法的潜力. 需要进一步的研究来优化NACT和免疫疗法组合,以获得更好的患者结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
妇科瘤学妇科瘤学

背景情况:

新辅助化疗 (NACT) 是许多妇科癌症的标准治疗方法.
瘤免疫微环境 (TIME) 在癌症进展和治疗反应中发挥着关键作用.
了解NACT对TIME的影响对于开发新型治疗策略至关重要.

研究的目的:

评估新辅助化疗 (NACT) 对妇科恶性瘤瘤免疫微环境 (TIME) 的影响.
探索将NACT与免疫疗法结合以增强抗瘤效果的潜力.

主要方法:

在PubMed,Embase和Cochrane数据库中的系统文献搜索.
包括审查,临床试验和案例研究,分析NACT在妇科瘤中对TIME的影响.
综合分析由NACT诱导的免疫细胞调节和TIME改变.

主要成果:

在不同的妇科癌症中,NACT会诱导TIME的变量变化.
在宫癌中,NACT增强了免疫促进细胞,有助于瘤清除.
卵巢癌的反应是异质的,受患者因素和NACT疗法的影响;对于子宫内膜癌,数据有限.

结论:

在妇科癌症中,NACT显著调节了TIME,为治疗干预提供了机会.
个性化免疫疗法在改善妇科瘤预后方面表现有前途.
需要进一步严格的研究来确定将NACT与免疫治疗结合的安全性和有效性.

关键词:

瘤的免疫微环境妇科瘤妇科瘤免疫疗法免疫疗法新辅助性化疗是一种新辅助性化疗.

更多相关视频

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...